Tata Chemicals Q3FY26 Results: Revenue ₹3,550 Cr, PAT ₹(15) Cr
Tata Chemicals reported Q3FY26 consolidated revenue of ₹3,550 crore and a PAT of ₹(15) crore. For the nine months ended December 31, 2025, revenue was ₹11,146 crore and PAT was ₹520 crore. The company highlighted lower soda ash realisations as a key factor. Several capacity expansions and acquisitions are underway, including a new salt plant in the UK and a Bi-carb plant in Singapore.
The results indicate a challenging quarter due to market conditions affecting realisations. However, ongoing strategic expansions and a strong balance sheet position the company for future growth, suggesting a moderate impact on investor sentiment.
While the company is executing strategic growth initiatives and capacity expansions, the financial results for Q3FY26 show a decline in revenue and a net loss, primarily due to lower soda ash realisations. The overall outlook is cautiously optimistic, focusing on long-term trends.
Tata Chemicals Limited has submitted an investor presentation detailing its Unaudited Consolidated and Audited Standalone financial results for the third quarter and nine months ended December 31, 2025. The presentation was made during an Analysts/Investors call held on February 2, 2026.
For the third quarter of FY26, consolidated revenue stood at ₹3,550 crore, a decrease from ₹3,877 crore in the previous quarter (Q2FY26) and ₹3,590 crore in the same quarter last year (Q3FY25). EBITDA for the quarter was ₹345 crore, down from ₹537 crore in Q2FY26 and ₹434 crore in Q3FY25. The company reported a Profit After Tax (PAT) of ₹(15) crore for Q3FY26, compared to ₹219 crore in Q2FY26 and ₹49 crore in Q3FY25. Net debt (external) increased to ₹5,596 crore as of December 2025 from ₹4,884 crore in March 2025. The company cited lower soda ash realisations as a primary factor impacting performance.
For the nine months ended December 31, 2025, consolidated revenue was ₹11,146 crore, slightly down from ₹11,378 crore in the same period last year. EBITDA for the nine months was ₹1,531 crore, a decrease from ₹1,626 crore in the prior year. PAT for the nine months stood at ₹520 crore, an increase from ₹491 crore in the previous year.
The company highlighted that performance for Q3FY26 and YTDFY26 was impacted by lower soda ash realisations. Fixed expenses and capex for YTDFY26 were lower than YTDFY25. Debt increased due to unfavorable market conditions and rupee depreciation, though the company maintains a robust balance sheet with a debt-to-equity ratio of 0.31.
Key strategic initiatives and project commissioning include the expansion of Soda Ash and Bi-carb plants in Mithapur, India, and a new salt plant in the UK, which are delivering additional volumes in FY26. The cessation of the Lostock UK soda ash plant in January 2025 helped stem EBITDA erosion. The company also announced the acquisition of a premium pharma-grade Bi-carb plant in Singapore in December 2025, commissioned a Pearl grade Silica plant in Cuddalore in November 2025, and a FOS L 55 plant in Mambattu in December 2025. A 50 KT Electric calciner soda ash plant in Kenya is expected to be operationalized by March 2026.
Geographically, India continues to experience robust growth, while China and the US are witnessing slight declines. Global demand is estimated to be flat in the near term with soda ash being well-supplied globally, leading to weak prices. However, the medium to long-term trend is positive, driven by sustainability applications.
What to do with a filing like this
Tata Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tata Chemicals Limited. Read the original for the full detail.